These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 27883876)
21. Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden. Liang WS; Vergilio JA; Salhia B; Huang HJ; Oki Y; Garrido-Laguna I; Park H; Westin JR; Meric-Bernstam F; Fabrizio D; Miller VA; Stephens PJ; Fanale MA; Ross JS; Janku F Oncologist; 2019 Feb; 24(2):219-228. PubMed ID: 30108156 [TBL] [Abstract][Full Text] [Related]
22. Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting. He J; Abdel-Wahab O; Nahas MK; Wang K; Rampal RK; Intlekofer AM; Patel J; Krivstov A; Frampton GM; Young LE; Zhong S; Bailey M; White JR; Roels S; Deffenbaugh J; Fichtenholtz A; Brennan T; Rosenzweig M; Pelak K; Knapp KM; Brennan KW; Donahue AL; Young G; Garcia L; Beckstrom ST; Zhao M; White E; Banning V; Buell J; Iwanik K; Ross JS; Morosini D; Younes A; Hanash AM; Paietta E; Roberts K; Mullighan C; Dogan A; Armstrong SA; Mughal T; Vergilio JA; Labrecque E; Erlich R; Vietz C; Yelensky R; Stephens PJ; Miller VA; van den Brink MR; Otto GA; Lipson D; Levine RL Blood; 2016 Jun; 127(24):3004-14. PubMed ID: 26966091 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy. Hilal T; Nakazawa M; Hodskins J; Villano JL; Mathew A; Goel G; Wagner L; Arnold SM; DeSimone P; Anthony LB; Hosein PJ BMC Cancer; 2017 Aug; 17(1):602. PubMed ID: 28854908 [TBL] [Abstract][Full Text] [Related]
24. Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin. Chmielecki J; Ross JS; Wang K; Frampton GM; Palmer GA; Ali SM; Palma N; Morosini D; Miller VA; Yelensky R; Lipson D; Stephens PJ Oncologist; 2015 Jan; 20(1):7-12. PubMed ID: 25480824 [TBL] [Abstract][Full Text] [Related]
25. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. Vignot S; Frampton GM; Soria JC; Yelensky R; Commo F; Brambilla C; Palmer G; Moro-Sibilot D; Ross JS; Cronin MT; André F; Stephens PJ; Lazar V; Miller VA; Brambilla E J Clin Oncol; 2013 Jun; 31(17):2167-72. PubMed ID: 23630207 [TBL] [Abstract][Full Text] [Related]
26. WWOX expression in giant cell lesions of the jaws. Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374 [TBL] [Abstract][Full Text] [Related]
27. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma. Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979 [TBL] [Abstract][Full Text] [Related]
28. The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws. Gomes CC; Diniz MG; Amaral FR; Antonini Guimarães BV; Gomez RS Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):583-5. PubMed ID: 25442495 [TBL] [Abstract][Full Text] [Related]
29. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms. Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923 [TBL] [Abstract][Full Text] [Related]
30. Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies. Ali SM; Sanford EM; Klempner SJ; Rubinson DA; Wang K; Palma NA; Chmielecki J; Yelensky R; Palmer GA; Morosini D; Lipson D; Catenacci DV; Braiteh F; Erlich R; Stephens PJ; Ross JS; Ou SH; Miller VA Oncologist; 2015 May; 20(5):499-507. PubMed ID: 25882375 [TBL] [Abstract][Full Text] [Related]
31. Immunoexpression of calcitonin and glucocorticoid receptors in central giant cell lesions of the jaws. Batista Severo ML; Lopes MLDS; Miguel MCDC; Germano AR; Nogueira RLM; Turatti E; Cavalcante RB; da Silveira ÉJD J Oral Pathol Med; 2018 Oct; 47(9):907-913. PubMed ID: 30028524 [TBL] [Abstract][Full Text] [Related]
32. Cytomorphometric and immunohistochemical comparison between central and peripheral giant cell lesions of the jaws. Flórez-Moreno GA; Henao-Ruiz M; Santa-Sáenz DM; Castañeda-Peláez DA; Tobón-Arroyave SI Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):625-32. PubMed ID: 18299236 [TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression in central giant cell lesion of the jaws: an immunohistochemical study. Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH J Mol Histol; 2012 Feb; 43(1):59-62. PubMed ID: 22042094 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies. Ross JS; Ali SM; Wang K; Palmer G; Yelensky R; Lipson D; Miller VA; Zajchowski D; Shawver LK; Stephens PJ Gynecol Oncol; 2013 Sep; 130(3):554-9. PubMed ID: 23791828 [TBL] [Abstract][Full Text] [Related]
35. Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'. De Falco V; Poliero L; Vitello PP; Ciardiello D; Vitale P; Zanaletti N; Giunta EF; Terminiello M; Caputo V; Carlino F; Di Liello R; Ventriglia A; Famiglietti V; Martinelli E; Morgillo F; Orditura M; De Vita F; Fasano M; Napolitano S; Martini G; Della Corte CM; Franco R; Altucci L; Ciardiello F; Troiani T ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32234730 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis. Dewsnup NC; Susarla SM; Abulikemu M; Faquin WC; Kaban LB; August M J Oral Maxillofac Surg; 2008 May; 66(5):928-33. PubMed ID: 18423282 [TBL] [Abstract][Full Text] [Related]
38. Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens. Müller JN; Falk M; Talwar J; Neemann N; Mariotti E; Bertrand M; Zacherle T; Lakis S; Menon R; Gloeckner C; Tiemann M; Heukamp LC; Thomas RK; Griesinger F; Heuckmann JM J Thorac Oncol; 2017 Oct; 12(10):1503-1511. PubMed ID: 28751246 [TBL] [Abstract][Full Text] [Related]